Saturday, September 5, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· July 18, 2026

Bank of America revamps Tesla forecast before earnings

View original at finance.yahoo.com
Bank of America revamps Tesla forecast before earnings Tesla (TSLA) CEO Elon Musk, whom JPMorgan CEO Jamie Dimon once called "our Einstein", has had plenty on his plate lately…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • BofA's quarterly model points to acceleration in Tesla's adjusted EPS, reaching $0.51 in Q2, $0.54 in Q3, and $0.68 in Q4 2026

    60% confidence
  • BofA raised its 2028 Tesla revenue estimate to $144 billion from $137.2 billion

    60% confidence
  • Jamie Dimon once called Elon Musk "our Einstein"

    60% confidence
  • Bank of America reiterated its Buy rating and $460 price target on Tesla, implying nearly 17.6% upside from Tesla's July 17 close of $391.06

    60% confidence
  • BofA lifted its 2026 Tesla revenue estimate to $107.8 billion from $103.4 billion

    60% confidence
  • BofA's Tesla EPS estimates jumped to $2.13, $2.71, and $3.39 for 2026, 2027, and 2028 respectively, representing increases of nearly 7%, 4%, and 4%

    60% confidence
  • BofA raised its 2027 Tesla revenue estimate to $126.2 billion from $120.4 billion

    60% confidence
  • Robotaxi is the primary catalyst spearheading Tesla's bull case, with Tesla entering the early monetization phase for robotaxis, FSD, Optimus, and energy storage

    60% confidence

Data points we hold from this source

SpaceX · stock price123.99 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com